These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
97 related items for PubMed ID: 2441191
1. Renal effects of 1,4-dihydropyridines in animal models of hypertension and renal failure. Garthoff B, Hirth C, Federmann A, Kazda S, Stasch JP. J Cardiovasc Pharmacol; 1987; 9 Suppl 1():S8-13. PubMed ID: 2441191 [Abstract] [Full Text] [Related]
2. Renal effects of calcium antagonists with special reference to manidipine hydrochloride. Rodicio JL. Blood Press Suppl; 1996; 5():10-5. PubMed ID: 8973787 [Abstract] [Full Text] [Related]
3. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats. Ishimitsu T, Honda T, Ohta S, Akashiba A, Takahashi T, Kameda T, Yoshii M, Minami J, Takahashi M, Ono H, Matsuoka H. Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768 [Abstract] [Full Text] [Related]
4. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs. Ueda M, Matsumura S, Masui M, Matsuura E, Kawakami M, Fujitomo H, Umeda T, Kagawa H, Hirohata S, Shima K. Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815 [Abstract] [Full Text] [Related]
5. Antihypertensive effects of lercanidipine in experimental hypertensive rats and dogs. Sironi G, Montagna E, Greto L, Bianchi G, Leonardi A, Testa R. Arzneimittelforschung; 1996 Feb; 46(2):145-52. PubMed ID: 8720303 [Abstract] [Full Text] [Related]
6. Effects of salt loading and nitrendipine on dihydropyridine receptors in hypertensive rats. Garthoff B, Bellemann P. J Cardiovasc Pharmacol; 1987 Feb; 10 Suppl 10():S36-9. PubMed ID: 2455136 [Abstract] [Full Text] [Related]
7. Nitrendipine and other calcium entry blockers (calcium antagonists) in hypertension. Kazda S, Garthoff B, Knorr A. Fed Proc; 1983 Feb; 42(2):196-200. PubMed ID: 6822291 [Abstract] [Full Text] [Related]
8. Antihypertensive effects of a new dihydropyridine calcium antagonist. Kimura Y, Fukui H, Tanaka M, Okamoto M, Morino A, Miura A, Kimura K, Enomoto H. Arzneimittelforschung; 1986 Sep; 36(9):1329-35. PubMed ID: 3790182 [Abstract] [Full Text] [Related]
9. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat. Gin T, Joon TL, Panagiotopoulos S, Cooper M, Taylor H, Jerums G. Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832 [Abstract] [Full Text] [Related]
10. Long-term blockade of the angiotensin II receptor in renin transgenic rats, salt-loaded Dahl rats, and stroke-prone spontaneously hypertensive rats. Stasch JP, Knorr A, Hirth-Dietrich C, Krämer T, Hübsch W, Dressel J, Fey P, Beuck M, Sander E, Frobel K, Kazda S. Arzneimittelforschung; 1997 Sep; 47(9):1016-23. PubMed ID: 9342414 [Abstract] [Full Text] [Related]
12. Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats. Karasawa A, Kubo K, Oka T, Nakamizo N. Arzneimittelforschung; 1988 Nov; 38(11A):1691-4. PubMed ID: 3219141 [Abstract] [Full Text] [Related]
13. Protective effect of a novel calcium blocker, S-312-d, on ischemic acute renal failure in rat. Shimizu T, Kawabata T, Nakamura M. J Pharmacol Exp Ther; 1990 Nov; 255(2):484-90. PubMed ID: 2243338 [Abstract] [Full Text] [Related]
14. Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes. Rumble JR, Doyle AE, Cooper ME. Am J Hypertens; 1995 Jan; 8(1):53-7. PubMed ID: 7734098 [Abstract] [Full Text] [Related]
15. Dihydropyridine calcium antagonists and agonists in the isolated perfused Dahl rat kidney. Steele TH, Challoner-Hue L. J Cardiovasc Pharmacol; 1987 Jan; 9 Suppl 1():S44-8. PubMed ID: 2441184 [Abstract] [Full Text] [Related]
16. Renoprotective effect of nisoldipine in rats with severe hypertension. Ishimitsu T, Ono H, Ogawa Y, Tsukada H, Oka K, Yagi S. J Hypertens; 1994 Jul; 12(7):751-9. PubMed ID: 7963503 [Abstract] [Full Text] [Related]
17. Nephroprotective effect of treatment with calcium channel blockers in spontaneously hypertensive rats. Sabbatini M, Vitaioli L, Baldoni E, Amenta F. J Pharmacol Exp Ther; 2000 Sep; 294(3):948-54. PubMed ID: 10945845 [Abstract] [Full Text] [Related]
18. Effects of nisoldipine on sympathetic activity, the renin-angiotensin-aldosterone system, and water-sodium-calcium metabolism in patients with essential hypertension. Iimura O, Kikuchi K, Shimamoto K, Nozawa A, Hasegawa R, Homma C, Komura H, Kobayakawa H. Arzneimittelforschung; 1989 Jun; 39(6):710-4. PubMed ID: 2775339 [Abstract] [Full Text] [Related]
19. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs. Narita H, Murata S, Yabana H, Kikkawa K, Sugawara Y, Akimoto Y, Nagao T. Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970 [Abstract] [Full Text] [Related]
20. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency. Bailey RR, Shand BI, Smith AH, Robson RA, Lynn KL. Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156 [Abstract] [Full Text] [Related] Page: [Next] [New Search]